{"title":"生命体征对 COVID-19 感染的日常反应:一位未接种疫苗的 70 岁男性 II 型糖尿病患者接受单克隆抗体和某些补充剂治疗的病例研究","authors":"Walter R Schumm","doi":"10.34297/ajbsr.2023.19.002602","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":502840,"journal":{"name":"American Journal of Biomedical Science & Research","volume":"191 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements\",\"authors\":\"Walter R Schumm\",\"doi\":\"10.34297/ajbsr.2023.19.002602\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":502840,\"journal\":{\"name\":\"American Journal of Biomedical Science & Research\",\"volume\":\"191 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Biomedical Science & Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34297/ajbsr.2023.19.002602\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Biomedical Science & Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34297/ajbsr.2023.19.002602","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Daily Response of Vital Signs to COVID-19 Infection: A Case Study of an Unvaccinated 70-Year-Old Male with Type II Diabetes Treated with Monoclonal Antibodies and Selected Supplements